Anti-Properdin Antibody (NM3086) Demonstrates Efficacy in a Primate Model of Wet-AMD and Dry-AMD
Figure 1 Fluoresceine angiogram data from three animals treated with NM3086 (bottom) and three that…
News
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on Monday, March 13, 2023
CAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Nexcella to Discuss Recent Positive NXC-201 Clinical Data In AL Amyloidosis and Multiple Myeloma at the 35th Annual Roth Conference on March 14
LOS ANGELES, March 06, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”),…
Windtree Finds Cardiogenic Shock Has High Cost of US Patient Care and Plans Innovation with the Unique Profile of Istaroxime
US Hospital Claims Data Reveals Cardiogenic Shock Patients Have an Average Hospital Length of Stay…
BioVie Announces Additional Findings from Phase 2 Parkinson’s Disease Trial: More patients treated with NE3107 experienced morning “on state” with levodopa withheld overnight compared to those treated with placebo
6 out of 20 patients treated with NE3107 experienced a morning “on state” while 0…
Medexus to Participate in 35th Annual Roth Conference
TORONTO and CHICAGO, March 06, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased…
FDA Approves UDENYCA® Autoinjector
– UDENYCA® is the only pegfilgrastim therapy delivered in a convenient, easy-to-administer prefilled autoinjector to…
ImmixBio to Discuss Recent Positive NXC-201 Clinical Data in AL Amyloidosis and Multiple Myeloma at the 35th Annual Roth Conference on March 14
LOS ANGELES, March 06, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”,…
Ikena Oncology Receives FDA Fast Track Designation for Novel AHR Antagonist IK-175 in Combination with Nivolumab to Treat Urothelial Carcinoma
BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC
–In Vitro Data Presentations Support Antithrombotic and Antioxidant Effects of EPA Compared with DHA, No…
SciSparc Successfully Completed Production of its Proprietary Drug Candidate SCI-110 for its Upcoming Clinical Trial On Tourette Syndrome
TEL AVIV, Israel, March 06, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company”…
Sensei Biotherapeutics to Participate in Oppenheimer’s 33rd Annual Healthcare Conference
BOSTON, March 06, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results
New Drug Application for VP-102 assigned PDUFA goal date of July 23, 2023 VP-102 has…
Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
Relay Therapeutics to host conference call following AACR presentation CAMBRIDGE, Mass., March 06, 2023 (GLOBE…
Federal Reserve Zoom Bombing Attack Was Preventable Zerify Offers U.S. Businesses a Secure Alternative
To Prove Our Point, Zerify is Offering a Three Month Free Trial of it’s Zerify Meet…
FourKites and Spotos Join Forces to Bring Real-time Supply Chain Visibility to European Shippers
FourKites and Spotos Join Forces Companies to Bring Real-time Supply Chain Visibility to European Shippers…
Orezone Intersects 1.72 g/t Gold Over 40.40m at P8P9 & 5.59 g/t Gold Over 15.00m at Maga
Figure 1 Bomboré Plan Map Overview Figure 2 P8P9 Cross Section 1350N Figure 3 P8P9…
Laser Love Unveils Clinically Proven Pain-Free Laser Hair Removal Technology in the Beauty Industry
Brooklyn, New York–(Newsfile Corp. – March 6, 2023) – Laser Love, a medical spa treatment…
RETRANSMISSION: Concerned Shareholders of Azimut Exploration Inc. Question the Company’s Business Strategy and Request for Shareholder Engagement and Improved Governance
Vancouver, British Columbia–(Newsfile Corp. – March 6, 2023) – Coloured Ties Capital Inc. (TSXV: TIE)…
Scope Carbon Announces Strategic Investment in Farm Flight
Scope’s partnership will align Scope and Farm Flight in developing industry-leading, analytical solutions in the…